Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been assigned a consensus rating of “Hold” from the sixteen analysts that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $23.1667.
Several equities analysts have weighed in on ACHC shares. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. Leerink Partnrs lowered shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Bank of America downgraded shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their price target for the stock from $21.50 to $13.00 in a report on Wednesday, December 3rd. Leerink Partners reissued a “market perform” rating and set a $14.00 price objective (down previously from $25.00) on shares of Acadia Healthcare in a research note on Wednesday, December 3rd. Finally, KeyCorp lowered their target price on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, December 3rd.
View Our Latest Stock Analysis on ACHC
Institutional Trading of Acadia Healthcare
Acadia Healthcare Stock Performance
ACHC opened at $14.28 on Friday. Acadia Healthcare has a 1-year low of $12.63 and a 1-year high of $47.08. The stock has a market cap of $1.32 billion, a P/E ratio of 12.21, a P/E/G ratio of 3.37 and a beta of 0.91. The stock’s 50 day simple moving average is $19.53 and its 200 day simple moving average is $21.37. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a return on equity of 7.66% and a net margin of 3.29%.The company had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. During the same period in the previous year, the business earned $0.91 earnings per share. Acadia Healthcare’s quarterly revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, equities analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories
- Five stocks we like better than Acadia Healthcare
- How to Invest in the Best Canadian Stocks
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- Why Are These Companies Considered Blue Chips?
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
